AACR logo

More articles from Immunology

In Vivo CRISPR Screen Identifies FLI1 as Regulator of Effector T Cells
Cancer Discovery May 2021, 11 (5) 1006; DOI: 10.1158/2159-8290.CD-RW2021-033
CD36 Activity Causes Ferroptosis in Tumor-Infiltrating CD8⁺ T Cells
Cancer Discovery May 2021, 11 (5) OF24; DOI: 10.1158/2159-8290.CD-RW2021-039
Mitochondrial DNA Damage Triggers an IFN-Mediated Immune Response
Cancer Discovery May 2021, 11 (5) 1004; DOI: 10.1158/2159-8290.CD-RW2021-031
Mutant p53 Aids Cancer Cells in Evading Lethal Innate Immune Responses
Cancer Discovery May 2021, 11 (5) OF14; DOI: 10.1158/2159-8290.CD-RW2021-022
Epstein–Barr Virus–Induced Antitumor Immune Response May Be Harnessable
Cancer Discovery Mar 2021, 11 (3) OF6; DOI: 10.1158/2159-8290.CD-RW2021-005
NK Cells Mediate T-cell Inflammation in the Tumor Microenvironment
Cancer Discovery Feb 2021, 11 (2) 223; DOI: 10.1158/2159-8290.CD-RW2020-174
MEK Inhibition Acts on CD8⁺ T Cells to Enhance Antitumor Immunity
Cancer Discovery Feb 2021, 11 (2) 221; DOI: 10.1158/2159-8290.CD-RW2020-176
HPV Antigen–Specific B Cells in Tumor Microenvironment Characterized
Cancer Discovery Feb 2021, 11 (2) 220; DOI: 10.1158/2159-8290.CD-RW2020-172
Genomic Screens Identify Genes That Regulate MHC-I Expression in DLBCL
Cancer Discovery Feb 2021, 11 (2) OF8; DOI: 10.1158/2159-8290.CD-RW2020-178
Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection
Cancer Discovery Feb 2021, 11 (2) OF7; DOI: 10.1158/2159-8290.CD-RW2020-188

Main menu